MJ BIOTECH, INC.
company.status.inactiveCIK 1543272fmd_153ZMDSEXZ5NG5J5QQPTBVMMKNServices · Services-Computer Programming, Data Processing, Etc.Template: Standard
Coverage: Jan 01, 2011 to Dec 31, 2018, 32 periods
Latest annual · FY2016
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (0)
- Net income
- (1)
Latest quarter · Q3 FY2018
Millions- Total revenues
- 0
- Operating income
- (0)
- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2013 to FY2016
- -13.0%
- Net income, 5 yearsFY2013 to FY2018
- n/m
MJ BIOTECH, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2018 | FY2017 | Change | Source |
|---|---|---|---|---|
| Net income | -$837,760 | -$1.1 million | 10-K 2019-07-11 · proof | |
| Cash from operating activities | -$33,081 | -$195,685 | 10-K 2019-07-11 · proof | |
| Total assets | $1 | $82 | -98.8% | 10-K 2019-07-11 · proof |
| Total liabilities | $2.5 million | $1.8 million | +37.8% | 10-K 2019-07-11 · proof |
| Cash and cash equivalents | $1 | $82 | -98.8% | 10-K 2019-07-11 · proof |
- What was MJ BIOTECH, INC.'s net income in fiscal 2018?
- MJ BIOTECH, INC. reported net income of -$837,760 for fiscal 2018 (the year ended Dec 31, 2018), against -$1.1 million the year before. Source: the 10-K filed with the SEC on Jul 11, 2019. SEC
- What was MJ BIOTECH, INC.'s cash from operating activities in fiscal 2018?
- MJ BIOTECH, INC. reported cash from operating activities of -$33,081 for fiscal 2018 (the year ended Dec 31, 2018), against -$195,685 the year before. Source: the 10-K filed with the SEC on Jul 11, 2019. SEC
- What are MJ BIOTECH, INC.'s total assets?
- As of Dec 31, 2018, MJ BIOTECH, INC. reported total assets of $1, against $82 a year earlier (-98.8%). Source: the 10-K filed with the SEC on Jul 11, 2019. SEC
- What are MJ BIOTECH, INC.'s total liabilities?
- As of Dec 31, 2018, MJ BIOTECH, INC. reported total liabilities of $2.5 million, against $1.8 million a year earlier (+37.8%). Source: the 10-K filed with the SEC on Jul 11, 2019. SEC
- What are MJ BIOTECH, INC.'s cash and cash equivalents?
- As of Dec 31, 2018, MJ BIOTECH, INC. reported cash and cash equivalents of $1, against $82 a year earlier (-98.8%). Source: the 10-K filed with the SEC on Jul 11, 2019. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1543272&period_type=annual&limit=5"Information only, not investment advice.